SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-339870
Filing Date
2017-11-13
Accepted
2017-11-13 07:46:00
Documents
4
Period of Report
2017-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d475947d8k.htm 8-K 21633
2 EX-99.1 d475947dex991.htm EX-99.1 9279
3 GRAPHIC g475947img01.jpg GRAPHIC 18367
4 GRAPHIC g475947img02.jpg GRAPHIC 7459
  Complete submission text file 0001193125-17-339870.txt   67856
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 171193152
SIC: 2834 Pharmaceutical Preparations